Elisa Sperti

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Preoperative mFOLFIRINOX versus PAXG for stage I-III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial.

Preoperative mFOLFIRINOX versus PAXG for stage I-III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial.

Journal: Lancet (London, England)

Published: April 13, 2025

Sexual health in cancer care: a narrative review and position statement from the Italian Association of Medical Oncology (AIOM).

Sexual health in cancer care: a narrative review and position statement from the Italian Association of Medical Oncology (AIOM).

Journal: ESMO open

Published: January 26, 2025

Cartoon: multicenter prospective observational study of Cardiovascular Toxicity of Trifluridine/Tipiracil in metastatic colorectal cancer.

Cartoon: multicenter prospective observational study of Cardiovascular Toxicity of Trifluridine/Tipiracil in metastatic colorectal cancer.

Journal: The oncologist

Published: January 03, 2025

Viral Hepatitis in Western Patients with Advanced Intrahepatic Cholangiocarcinoma: Retrospective Assessment of Prevalence, Prognostic and Predictive Significance.

Viral Hepatitis in Western Patients with Advanced Intrahepatic Cholangiocarcinoma: Retrospective Assessment of Prevalence, Prognostic and Predictive Significance.

Journal: Cancer investigation

Published: November 27, 2024

Title Not Found

Title Not Found

Journal: Recenti progressi in medicina

Published: November 17, 2024

Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study.

Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study.

Journal: BMC cancer

Published: May 06, 2024

Adoption of electronic patient-reported outcomes in cancer clinical practice: the point of view of Italian patients.

Adoption of electronic patient-reported outcomes in cancer clinical practice: the point of view of Italian patients.

Journal: ESMO real world data and digital oncology

Published: February 19, 2024

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study.

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study.

Journal: BMC cancer

Published: December 19, 2023

Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study.

Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study.

Journal: Journal of endocrinological investigation

Published: July 14, 2023

Risk-adjusted analysis of survival variability among hospitals treating biliary malignancy.

Risk-adjusted analysis of survival variability among hospitals treating biliary malignancy.

Journal: Journal of chemotherapy (Florence, Italy)

Published: February 14, 2022

A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index.

A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index.

Journal: Journal of gastrointestinal cancer

Published: May 13, 2021

A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step?

A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step?

Journal: Exploration of targeted anti-tumor therapy

Published: January 01, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026